Edwin Charles Gravereaux, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Abdominal | 12 | 2022 | 1250 | 0.450 |
Why?
|
| Stents | 11 | 2016 | 3193 | 0.350 |
Why?
|
| Vascular Surgical Procedures | 7 | 2019 | 1506 | 0.340 |
Why?
|
| Endarterectomy, Carotid | 1 | 2014 | 556 | 0.310 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 858 | 0.270 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2024 | 538 | 0.270 |
Why?
|
| Blood Vessel Prosthesis Implantation | 7 | 2022 | 1456 | 0.270 |
Why?
|
| Angioplasty | 3 | 2002 | 355 | 0.240 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2004 | 488 | 0.240 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2015 | 707 | 0.230 |
Why?
|
| Peripheral Arterial Disease | 3 | 2024 | 1304 | 0.210 |
Why?
|
| Lithotripsy | 1 | 2023 | 137 | 0.200 |
Why?
|
| Intermittent Claudication | 3 | 2016 | 305 | 0.190 |
Why?
|
| Blood Vessel Prosthesis | 6 | 2003 | 956 | 0.190 |
Why?
|
| Spinal Cord Ischemia | 1 | 2001 | 94 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1055 | 0.160 |
Why?
|
| Iliac Artery | 4 | 2003 | 344 | 0.150 |
Why?
|
| Aortography | 3 | 2015 | 423 | 0.150 |
Why?
|
| Popliteal Artery | 3 | 2016 | 313 | 0.150 |
Why?
|
| Angioplasty, Balloon | 2 | 2016 | 592 | 0.140 |
Why?
|
| Emergencies | 2 | 2021 | 1223 | 0.130 |
Why?
|
| Ischemia | 4 | 2016 | 1905 | 0.130 |
Why?
|
| Endovascular Procedures | 3 | 2022 | 2215 | 0.130 |
Why?
|
| Anatomy | 1 | 2017 | 126 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2019 | 768 | 0.130 |
Why?
|
| Femoral Artery | 3 | 2016 | 827 | 0.120 |
Why?
|
| Aorta, Abdominal | 2 | 2015 | 627 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 1403 | 0.110 |
Why?
|
| Limb Salvage | 3 | 2024 | 488 | 0.110 |
Why?
|
| Endoleak | 1 | 2013 | 111 | 0.110 |
Why?
|
| Arteries | 2 | 2011 | 1123 | 0.100 |
Why?
|
| Stroke | 1 | 2014 | 9746 | 0.100 |
Why?
|
| Angiography | 5 | 2016 | 1597 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2005 | 743 | 0.090 |
Why?
|
| Lower Extremity | 2 | 2016 | 1217 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1701 | 0.090 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 671 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2016 | 1220 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 806 | 0.080 |
Why?
|
| Leg | 2 | 2004 | 1087 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 263 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 1263 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2598 | 0.070 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1119 | 0.070 |
Why?
|
| Prosthesis Failure | 2 | 2003 | 1208 | 0.070 |
Why?
|
| Treatment Outcome | 13 | 2023 | 65295 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3618 | 0.070 |
Why?
|
| General Surgery | 1 | 2017 | 1720 | 0.060 |
Why?
|
| Inguinal Canal | 1 | 2005 | 71 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 198 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2004 | 71 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 2030 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2015 | 20741 | 0.050 |
Why?
|
| Risk Factors | 8 | 2024 | 74886 | 0.050 |
Why?
|
| Carotid Artery, Common | 1 | 2003 | 172 | 0.050 |
Why?
|
| Vascular Patency | 3 | 2016 | 915 | 0.050 |
Why?
|
| Saphenous Vein | 1 | 2005 | 519 | 0.050 |
Why?
|
| Vascular Grafting | 1 | 2024 | 163 | 0.050 |
Why?
|
| Knee Joint | 1 | 2011 | 1683 | 0.050 |
Why?
|
| Endoscopy | 2 | 2002 | 1854 | 0.050 |
Why?
|
| Follow-Up Studies | 12 | 2015 | 39317 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 2764 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3700 | 0.050 |
Why?
|
| Cholecystitis | 1 | 2002 | 181 | 0.050 |
Why?
|
| Iliac Aneurysm | 1 | 2001 | 37 | 0.050 |
Why?
|
| Time Factors | 9 | 2022 | 40154 | 0.050 |
Why?
|
| Vascular Fistula | 1 | 2001 | 50 | 0.050 |
Why?
|
| Viscera | 1 | 2002 | 138 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2003 | 250 | 0.050 |
Why?
|
| Paraplegia | 1 | 2001 | 161 | 0.050 |
Why?
|
| Cholelithiasis | 1 | 2002 | 408 | 0.050 |
Why?
|
| Aged | 20 | 2024 | 171319 | 0.050 |
Why?
|
| Intestinal Fistula | 1 | 2001 | 146 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2011 | 1389 | 0.040 |
Why?
|
| Male | 22 | 2024 | 364203 | 0.040 |
Why?
|
| Morbidity | 2 | 2001 | 1754 | 0.040 |
Why?
|
| Postoperative Complications | 6 | 2022 | 15824 | 0.040 |
Why?
|
| Humans | 31 | 2024 | 767040 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2001 | 540 | 0.040 |
Why?
|
| Female | 22 | 2024 | 396660 | 0.040 |
Why?
|
| Blood Cells | 1 | 2000 | 309 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2003 | 649 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1233 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 2003 | 872 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 924 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10393 | 0.030 |
Why?
|
| Steroids | 1 | 2001 | 937 | 0.030 |
Why?
|
| Lymphedema | 1 | 2003 | 526 | 0.030 |
Why?
|
| Polymers | 1 | 2023 | 1624 | 0.030 |
Why?
|
| Drainage | 1 | 2001 | 1183 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1368 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2001 | 741 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 1110 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1207 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 598 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 935 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2015 | 331 | 0.030 |
Why?
|
| Aorta | 1 | 2021 | 2045 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2024 | 81659 | 0.030 |
Why?
|
| Cadaver | 1 | 2017 | 1362 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 1104 | 0.030 |
Why?
|
| Comorbidity | 3 | 2002 | 10582 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 977 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 1512 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1804 | 0.020 |
Why?
|
| Equipment Design | 2 | 2015 | 3489 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4525 | 0.020 |
Why?
|
| Middle Aged | 10 | 2024 | 223233 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 13085 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15424 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 4052 | 0.020 |
Why?
|
| Renal Artery | 2 | 2002 | 355 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12250 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8535 | 0.020 |
Why?
|
| Probability | 2 | 2005 | 2476 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2001 | 3464 | 0.020 |
Why?
|
| Netherlands | 1 | 2014 | 2277 | 0.020 |
Why?
|
| Extremities | 1 | 2014 | 870 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2014 | 903 | 0.020 |
Why?
|
| Transgenes | 2 | 2003 | 1014 | 0.020 |
Why?
|
| Disease Progression | 2 | 2015 | 13646 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2016 | 1965 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4424 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 3928 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12069 | 0.020 |
Why?
|
| Radiography | 3 | 2004 | 6975 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2022 | 24299 | 0.020 |
Why?
|
| Stem Cells | 1 | 2000 | 3535 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6513 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 2003 | 2120 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 8504 | 0.010 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 59548 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9360 | 0.010 |
Why?
|
| Critical Illness | 1 | 2016 | 2753 | 0.010 |
Why?
|
| Survival Rate | 2 | 2012 | 12823 | 0.010 |
Why?
|
| Foreign-Body Reaction | 1 | 2003 | 156 | 0.010 |
Why?
|
| Brachiocephalic Trunk | 1 | 2002 | 40 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2003 | 125 | 0.010 |
Why?
|
| Tibial Arteries | 1 | 2002 | 60 | 0.010 |
Why?
|
| Celiac Artery | 1 | 2002 | 65 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2003 | 118 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2002 | 96 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3370 | 0.010 |
Why?
|
| Subclavian Artery | 1 | 2002 | 138 | 0.010 |
Why?
|
| Graft Rejection | 2 | 2005 | 4498 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2017 | 4859 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2014 | 41718 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2002 | 177 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13284 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 939 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8732 | 0.010 |
Why?
|
| Sutures | 1 | 2003 | 283 | 0.010 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2002 | 236 | 0.010 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 1251 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 2118 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 547 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9362 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 832 | 0.010 |
Why?
|
| Incidence | 2 | 2012 | 21526 | 0.010 |
Why?
|
| Massachusetts | 1 | 2012 | 8890 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 748 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14672 | 0.010 |
Why?
|
| Metals | 1 | 2003 | 711 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2002 | 934 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6489 | 0.010 |
Why?
|
| Pelvis | 1 | 2001 | 736 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 15925 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4751 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4572 | 0.010 |
Why?
|
| Graft Survival | 1 | 2005 | 3896 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 4325 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 1612 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2012 | 54886 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4473 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 7236 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8310 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13411 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 12536 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5311 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 17608 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2000 | 5891 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 4256 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11063 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 3511 | 0.010 |
Why?
|
| Sepsis | 1 | 2001 | 2605 | 0.000 |
Why?
|
| Gene Expression | 1 | 2000 | 7587 | 0.000 |
Why?
|
| United States | 1 | 2014 | 72971 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2000 | 18989 | 0.000 |
Why?
|
| Adult | 2 | 2014 | 223317 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 18330 | 0.000 |
Why?
|
| Animals | 1 | 2003 | 168965 | 0.000 |
Why?
|